Authors: Mahalati, K Belitsky, P West, K Kiberd, B Fraser, A Sketris, I Macdonald, AS McAlister, V Lawen, J

Citation: K. Mahalati et al., Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study, J AM S NEPH, 12(4), 2001, pp. 828-833

Authors: Pearson, GJ Cooke, C Simmons, WKT Sketris, I

Citation: Gj. Pearson et al., Evaluation of the use of evidence-based angiotensin-converting enzyme inhibitor criteria for the treatment of congestive heart failure: opportunitiesfor pharmacists to improve patient outcomes, J CLIN PH T, 26(5), 2001, pp. 351-361

Authors: Kephart, G Sketris, I MacLean, D Kass, K Nagpal, S

Citation: G. Kephart et al., Management of high blood cholesterol levels in Nova Scotian adults: Comparison with the NCEP II and European clinical practice guidelines, AM J M CARE, 6(9), 2000, pp. 1017-1028

Authors: Wolf, HK Andreou, P Bata, IR Comeau, DG Gregor, RD Kephart, G MacLean, DR Sketris, I

Citation: Hk. Wolf et al., Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995, CAN MED A J, 161(6), 1999, pp. 699-704

Authors: Belitsky, P Mahalati, K West, K Sketris, I

Citation: P. Belitsky et al., Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve, TRANSPLAN P, 31(3), 1999, pp. 1667-1668

Authors: Mahalati, K Belitsky, P Sketris, I West, K Panek, R

Citation: K. Mahalati et al., Neoral monitoring by simplified sparse sampling area under the concentration-time curve - Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation, TRANSPLANT, 68(1), 1999, pp. 55-62